JB Chemicals & Pharmaceuticals Limited — Board Meeting, 16-01-2026: Outcome of Board Meeting

J.B. Chemicals & Pharma announced a board meeting where it approved consolidated financial results for Q3 & nine months ending Dec 31, 2025. Q3 revenue hit ₹1064.72 Cr; net profit ₹197.89 Cr. The board also noted the ongoing merger with Torrent Pharma, offering 51 shares for every 100 JBCP shares, with CCI approval secured.